Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection

PLoS Pathogens

Volumn 12, Issue 6, 2016, Pages

  Shang, Shaobin ^a   Siddiqui, Sarah ^a   Bian, Yao ^a   Zhao, Jie ^a   Wang, Chyung Ru ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOBACTERIUM ANTIGEN; BACTERIAL ANTIGEN; HLA ANTIGEN CLASS 1; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HOST RESISTANCE; IMMUNOSTIMULATION; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MEMORY T LYMPHOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULOSIS; ANIMAL; C57BL MOUSE; CYTOTOXICITY; DISEASE MODEL; IMMUNOLOGY; MUTANT MOUSE STRAIN; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, BACTERIAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYCOBACTERIUM TUBERCULOSIS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84978811478     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005688     Document Type: Article

References (65)

1. WHOGlobal Tuberculosis Report 2015. 2015 ed.Geneva: WHO Press.; 2015.
2. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA: the journal of the American Medical Association. 1994;271(9):698–702. 8309034.
3. Cooper AM, Cell-mediated immune responses in tuberculosis. Annual review of immunology. 2009;27:393–422. doi: 10.1146/annurev.immunol.021908.13270319302046.
4. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL, Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol. 1999;162(9):5407–16. 10228018.
5. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ, The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. The Journal of experimental medicine. 2001;193(3):271–80. 11157048; PubMed Central PMCID: PMC2195922.
6. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM, Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of experimental medicine. 1993;178(6):2243–7. 8245795; PubMed Central PMCID: PMC2191280.
7. Orme IM, Collins FM, Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. The Journal of experimental medicine. 1983;158(1):74–83. 6602861; PubMed Central PMCID: PMC2187069.
8. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR, Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(24):12013–7. 1465432; PubMed Central PMCID: PMC50688.
9. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P, Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. European journal of immunology. 2000;30(12):3689–98. doi: 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2–411169412.
10. Behar SM, Antigen-specific CD8(+) T cells and protective immunity to tuberculosis. Advances in experimental medicine and biology. 2013;783:141–63. doi: 10.1007/978-1-4614-6111-1_823468108.
11. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hong S, et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(8):4204–8. 10760288.
12. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP, The immune response in tuberculosis. Annual review of immunology. 2013;31:475–527. doi: 10.1146/annurev-immunol-032712-09593923516984.
13. Ottenhoff TH, Kaufmann SH, Vaccines against tuberculosis: where are we and where do we need to go?PLoS pathogens. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.100260722589713; PubMed Central PMCID: PMC3349743.
14. Rodgers JR, Cook RG, MHC class Ib molecules bridge innate and acquired immunity. Nature reviews. 2005;5(6):459–71. doi: 10.1038/nri163515928678.
15. Hofstetter AR, Sullivan LC, Lukacher AE, Brooks AG, Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity. Current opinion in immunology. 2011;23(1):104–10. doi: 10.1016/j.coi.2010.09.00920970974.
16. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, et al. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. The Journal of experimental medicine. 2001;193(10):1213–20. 11369792; PubMed Central PMCID: PMC2193330.
17. Doi T, Yamada H, Yajima T, Wajjwalku W, Hara T, Yoshikai Y, H2-M3-restricted CD8+ T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis. J Immunol. 2007;178(6):3806–13. 17339479.
18. Zhou D, Mattner J, Cantu C, 3rdSchrantz N, Yin N, Gao Y, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science. 2004;306(5702):1786–9. doi: 10.1126/science.110344015539565.
19. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005;434(7032):520–5. doi: 10.1038/nature0340715791257.
20. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM, Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS pathogens. 2008;4(12):e1000239. doi: 10.1371/journal.ppat.100023919079582; PubMed Central PMCID: PMC2588496.
21. Rothchild AC, Jayaraman P, Nunes-Alves C, Behar SM, iNKT cell production of GM-CSF controls Mycobacterium tuberculosis. PLoS pathogens. 2014;10(1):e1003805. doi: 10.1371/journal.ppat.100380524391492; PubMed Central PMCID: PMC3879349.
22. Kasmar AG, van Rhijn I, Cheng TY, Turner M, Seshadri C, Schiefner A, et al. CD1b tetramers bind alphabeta T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. The Journal of experimental medicine. 2011;208(9):1741–7. doi: 10.1084/jem.2011066521807869; PubMed Central PMCID: PMC3171094.
23. Montamat-Sicotte DJ, Millington KA, Willcox CR, Hingley-Wilson S, Hackforth S, Innes J, et al. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. The Journal of clinical investigation. 2011;121(6):2493–503. doi: 10.1172/JCI4621621576820; PubMed Central PMCID: PMC3104771.
24. Felio K, Nguyen H, Dascher CC, Choi HJ, Li S, Zimmer MI, et al. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. The Journal of experimental medicine. 2009;206(11):2497–509. doi: 10.1084/jem.2009089819808251; PubMed Central PMCID: PMC2768849.
25. Zhao J, Siddiqui S, Shang S, Bian Y, Bagchi S, He Y, et al. Mycolic acid-specific T Cells protect against infection in a humanized transgenic mouse model. eLife. 2015;4:pii: e08525. doi: 10.7554/eLife.0852526652001.
26. Birkinshaw RW, Kjer-Nielsen L, Eckle SB, McCluskey J, Rossjohn J, MAITs, MR1 and vitamin B metabolites. Current opinion in immunology. 2014;26:7–13. doi: 10.1016/j.coi.2013.09.00724556396.
27. Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH, Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infection and immunity. 2012;80(9):3256–67. doi: 10.1128/IAI.00279-1222778103; PubMed Central PMCID: PMC3418730.
28. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS biology. 2010;8(6):e1000407. doi: 10.1371/journal.pbio.100040720613858; PubMed Central PMCID: PMC2893946.
29. Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, Streblow DN, et al. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. The Journal of experimental medicine. 2002;196(11):1473–81. 12461082; PubMed Central PMCID: PMC2194265.
30. Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, et al. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS pathogens. 2010;6(2):e1000782. doi: 10.1371/journal.ppat.100078220195504; PubMed Central PMCID: PMC2829052.
31. Urdahl KB, Liggitt D, Bevan MJ, CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection. J Immunol. 2003;170(4):1987–94. 12574368.
32. Rolph MS, Raupach B, Kobernick HH, Collins HL, Perarnau B, Lemonnier FA, et al. MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis. European journal of immunology. 2001;31(6):1944–9. 11433392.
33. Schaible UE, Collins HL, Priem F, Kaufmann SH, Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. The Journal of experimental medicine. 2002;196(11):1507–13. 12461085; PubMed Central PMCID: PMC2194267.
34. Cho H, Choi HJ, Xu H, Felio K, Wang CR, Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3. J Immunol. 2011;186(1):489–98. doi: 10.4049/jimmunol.100263921098224; PubMed Central PMCID: PMC3068915.
35. Wherry EJ, T cell exhaustion. Nature immunology. 2011;12(6):492–9. 21739672.
36. Wang CR, Castano AR, Peterson PA, Slaughter C, Lindahl KF, Deisenhofer J, Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell. 1995;82(4):655–64. 7664344.
37. Swanson PA, 2ndPack CD, Hadley A, Wang CR, Stroynowski I, Jensen PE, et al. An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. The Journal of experimental medicine. 2008;205(7):1647–57. doi: 10.1084/jem.2008057018541714; PubMed Central PMCID: PMC2442642.
38. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717–23. doi: 10.1038/nature1160523051753.
39. Tough DF, Borrow P, Sprent J, Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science New York, NY. 1996;272(5270):1947–50. 8658169.
40. Brigl M, Tatituri RV, Watts GF, Bhowruth V, Leadbetter EA, Barton N, et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. The Journal of experimental medicine. 2011;208(6):1163–77. doi: 10.1084/jem.2010255521555485; PubMed Central PMCID: PMC3173255.
41. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol. 2009;182(12):8047–55. doi: 10.4049/jimmunol.080159219494330.
42. Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N, Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Frontiers in immunology. 2014;5:180. doi: 10.3389/fimmu.2014.0018024795723; PubMed Central PMCID: PMC4001014.
43. Wilkinson KA, Wilkinson RJ, Polyfunctional T cells in human tuberculosis. European journal of immunology. 2010;40(8):2139–42. doi: 10.1002/eji.20104073120853500.
44. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. European journal of immunology. 2010;40(8):2211–20. doi: 10.1002/eji.20104045520540114.
45. Billeskov R, Vingsbo-Lundberg C, Andersen P, Dietrich J, Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J Immunol. 2007;179(6):3973–81. 17785835.
46. Soloski MJ, Hood L, Stroynowski I, Qa-region class I gene expression: identification of a second class I gene, Q9, encoding a Qa-2 polypeptide. Proceedings of the National Academy of Sciences of the United States of America. 1988;85(9):3100–4. 3362864; PubMed Central PMCID: PMC280151.
47. Nakayama K, Tokito S, Pannetier C, Nakauchi H, Gachelin G, MHC gene Q8/9d of the BALB/cJ mouse strain cannot encode a Qa-2,3 class I antigen. Immunogenetics. 1991;33(4):225–34. 2026459.
48. Chiang EY, Stroynowski I, A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor. J Immunol. 2004;173(7):4394–401. 15383569.
49. Wong EB, Sullivan Z, Gold M, Lalloo U, Ambaram A, Baijnath P, et al. MAIT Cells are Highly Enriched in the Bronchoalveolar Lavage Fluid of Patients with TB. Conference on retroviruses and opportunistic infections; March 3–6; Boston, Massachusetts: IAS–USA/CROI Foundation; 2014. p. A820.
50. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nature immunology. 2010;11(8):701–8. doi: 10.1038/ni.189020581831.
51. Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SB, Meehan B, et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. The Journal of experimental medicine. 2015;212(7):1095–108. doi: 10.1084/jem.2014211026101265; PubMed Central PMCID: PMC4493408.
52. Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H, et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. The Journal of experimental medicine. 1999;189(12):1907–21. 10377186; PubMed Central PMCID: PMC2192962.
53. Tabaczewski P, Chiang E, Henson M, Stroynowski I, Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides. J Immunol. 1997;159(6):2771–81. 9300698.
54. Chen L, Jay DC, Fairbanks JD, He X, Jensen PE, An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. J Immunol. 2011;187(12):6463–72. doi: 10.4049/jimmunol.110117122084437.
55. Comiskey M, Goldstein CY, De Fazio SR, Mammolenti M, Newmark JA, Warner CM, Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product. Human immunology. 2003;64(11):999–1004. 14602227; PubMed Central PMCID: PMC2530818.
56. Li S, Choi HJ, Felio K, Wang CR, Autoreactive CD1b-restricted T cells: a new innate-like T-cell population that contributes to immunity against infection. Blood. 2011;118(14):3870–8. doi: 10.1182/blood-2011-03-34194121860021; PubMed Central PMCID: PMC3193264.
57. Chiu NM, Wang B, Kerksiek KM, Kurlander R, Pamer EG, Wang CR, The selection of M3-restricted T cells is dependent on M3 expression and presentation of N-formylated peptides in the thymus. The Journal of experimental medicine. 1999;190(12):1869–78. 10601361; PubMed Central PMCID: PMC2195718.
58. Seaman MS, Wang CR, Forman J, MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol. 2000;165(9):5192–201. 11046052.
59. Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH, Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. The Journal of experimental medicine. 1998;187(10):1633–40. 9584141; PubMed Central PMCID: PMC2212289.
60. Lewinsohn DM, Briden AL, Reed SG, Grabstein KH, Alderson MR, Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol. 2000;165(2):925–30. 10878367.
61. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, Nguyen H, et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. The Journal of experimental medicine. 2003;197(7):907–18. doi: 10.1084/jem.2002136612682110; PubMed Central PMCID: PMC2193895.
62. Flaherty L, DiBiase K, Lynes MA, Seidman JG, Weinberger O, Rinchik EM, Characterization of a Q subregion gene in the murine major histocompatibility complex. Proceedings of the National Academy of Sciences of the United States of America. 1985;82(5):1503–7. 2983348; PubMed Central PMCID: PMC397291.
63. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164–9. doi: 10.1038/nature0143312634786.
64. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H, Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nature immunology. 2004;5(5):516–23. doi: 10.1038/ni106315098030.
65. Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z, Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. Journal of immunology. 2004;173(7):4590–7. 15383593.